US-based intraocular lens developer PowerVision closed its series C round at $37.2m it has emerged, as it added Johnson & Johnson Development Corporation (JJDC) to its pool of investors, on 22nd December.
JJDC joined venture capital (VC) firms Advanced Technology Ventures, Venrock and Frazier Healthcare Ventures, all existing investors, in the round’s final closing. Medical technology company Medtronic and VC firm Panorama Capital participated in the round’s initial closing, in July last year.
The intraocular lens implants PowerVision is developing…
